Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia

被引：4

作者：

Perez-Esparza, Rodrigo ^{[1
,2
]}

Onate-Cadena, Nelcy ^{[1
]}

Ramirez-Bermudez, Jesus ^{[1
]}

Espinola-Nadurille, Mariana ^{[1
]}

机构：

[1] Natl Inst Neurol & Neurosurg, Dept Neuropsychiat, Mexico City, DF, Mexico

[2] Natl Inst Neurol & Neurosurg, Addict Res Lab, Insurgentes Sur 3877, Mexico City 14269, DF, Mexico

来源：

NEUROLOGIST | 2018年 / 23卷 / 02期

关键词：

hyperammonemia; catatonia; valproate; valproic acid; encephalopathy; ACID;

D O I：

10.1097/NRL.0000000000000166

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Hyperammonemic encephalopathy secondary to the use of valproate is rare without evidence of hepatotoxicity, and it usually presents with confusion, agitation, irritability, cognitive disturbances, lethargy, coma, and death. We present the case of a 21-year-old woman presenting with catatonia as a manifestation of hyperammonemic encephalopathy that resolved with the normalization of ammonia and suspension of valproate.

引用

页码：51 / 52

页数：2

共 50 条

[31] Free Paper On Valproate Induced Hyperammonemic Encephalopathy
Chauhan, Vinay
INDIAN JOURNAL OF PSYCHIATRY, 2016, 58 (05) : S162 - S162
[32] Valproate-induced encephalopathy with predominant pancerebellar syndrome
Verma, Rajesh
Kori, Prakash
INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (01): : 129 - 130
[33] Valproate-Induced Encephalopathy Presenting at Therapeutic Blood Concentrations: A Case Report and Literature Review
Pavar, Gautham
Xu, Nicole
Sawar, Kinan
Trivedi, Vichar
Levine, Diane L.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
[34] A case of valproate-induced hyperammonaemic encephalopathy
Lucie, O.
Nazir, F.
Spilg, E.
SCOTTISH MEDICAL JOURNAL, 2013, 58 (01) : E43 - E44
[35] A valproate-induced encephalopathy without hyperammonemia
Parize, P.
Beuret, P.
Fischer, C.
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2007, 26 (12): : 1084 - 1085
[36] Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam
Lokrantz, CM
Eriksson, B
Rosén, I
Asztely, F
ACTA NEUROLOGICA SCANDINAVICA, 2004, 109 (04): : 297 - 301
[37] Non-hyperammonaemia valproate-induced encephalopathy: A case report
Chen, Ling
Xu, Zucai
Huang, Hao
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (03) : 415 - 419
[38] Role of valproate in hyperammonemic encephalopathy in women in a tertiary psychiatric clinic
Yildizhan, Eren
Tomruk, Nesrin Buket
Ozdemir, Armagan
Kacar, Mehmetcan
Celik, Yasemin
Yilmaz, Dogan
Varlik, Cenk
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2019, 20 (06): : 589 - 596
[39] Valproate-induced encephalopathy:: Assessment with MR imaging and 1H MR spectroscopy
Ziyeh, S
Thiel, T
Spreer, J
Klisch, J
Schumacher, M
EPILEPSIA, 2002, 43 (09) : 1101 - 1105
[40] Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting
Dealberto, Marie-Jose C. C.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (06) : 330 - 337

← 1 2 3 4 5 →